RIVANOVA
Manufacturing
Four dedicated production blocks, 1,40,000 sq. ft. of controlled space, and a batch record that can be reconstructed to the minute.
Production blocks
Cross-contamination is not managed by procedure alone — it is designed out. Each dosage form has its own block, its own air handling and its own material path from dispensing to despatch.
Tablets and capsules across four compression suites and three encapsulation lines. Humidity held below 45% RH throughout, with dedicated granulation, drying, blending and coating rooms linked by airlocked corridors.
Syrups, suspensions and dry syrups produced in closed-loop stainless steel vessels with in-line homogenisation. Purified water is drawn from a continuously circulating loop held above 65 °C and monitored for TOC and conductivity.
Grade A/B aseptic core for dry-powder and liquid vials, with Grade C and D support zones. Continuous viable and non-viable particle monitoring, media fills every six months, and 100% visual inspection before packing.
Creams, ointments, gels and lotions in vacuum homogenising vessels, alongside dehumidified blending suites for clinical nutrition and nutraceutical powders.
The batch journey
No stage proceeds without documented clearance from the previous one. The batch record is built as the batch is made, not reconstructed afterwards.
Every incoming consignment is quarantined on arrival. Nothing is accepted on the supplier's certificate alone — identity, assay and impurity profile are re-tested in our own laboratory.
Actives and excipients are weighed under laminar airflow in a dedicated dispensing booth, double-verified against the batch manufacturing record by two operators.
Wet or dry granulation for solids; closed-vessel compounding for liquids and semi-solids. Process parameters are recorded continuously, not sampled.
In-process controls run throughout: weight variation, hardness, friability, disintegration for solids; fill volume and clarity for liquids and injectables.
Film, enteric or sustained-release coating applied in perforated auto-coaters, followed by 100% visual or automated inspection for defects.
Blistering, bottling or tube filling under line clearance, with online code verification, leak testing and reconciliation of every printed component.
Assay, dissolution, uniformity of content, microbial limits and related substances tested against the pharmacopoeial monograph before any release decision.
Quality assurance reviews the complete batch record, deviation history and audit trails — then releases, or does not. Retention samples are stored for shelf life plus one year.
Installed capacity
We run at roughly 72% utilisation by design. Headroom is what allows us to absorb a demand spike without compressing cleaning, changeover or testing time.
Customer and regulatory audits are scheduled with three weeks' notice. We hold an audit-ready state year-round.
Third-party manufacturing under your brand with full technology transfer and NDA-governed confidentiality.